Search results
Results from the WOW.Com Content Network
Whitehead Institute for Biomedical Research (Massachusetts Institute of Technology) Missouri. McDonnell Genome Institute (Washington University in St. Louis) New Mexico. National Center for Genome Resources; New York. Cold Spring Harbor Laboratory; Icahn Institute for Genomics and Multiscale Biology (Icahn School of Medicine) New York Genome Center
In March 2013, Complete Genomics was acquired by BGI Group. [17] After the acquisition, Complete Genomics moved to San Jose, and in June 2018 became part of MGI. [18] [19] The acquisition was the one of the outcomes of $1.5 billion 'collaborative funds' i.e., '10 years loan' which was initially provided by China Development Bank to acquire all 128 of Illumina, Inc.'s newest and fastest next ...
In 2002, BGI sequenced the rice genome, which was a cover story in the journal Science. In 2003, BGI decoded the SARS virus genome and created a kit for detection of the virus. [ 19 ] In 2003, the Chinese Academy of Sciences founded the Beijing Institute of Genomics in cooperation with BGI, with Yang Huanming as its first director.
This has enabled a drastic increase in available sequence data and fundamentally changed genome sequencing approaches in the biomedical sciences. [9] Newly emerging NGS technologies and instruments have further contributed to a significant decrease in the cost of sequencing nearing the mark of $1000 per genome sequencing. [10] [11]
Illumina also uses the DNA colony sequencing technology, invented in 1997 by Pascal Mayer and Laurent Farinelli [8] and which was acquired by Solexa in 2004 from Manteia Predictive Medicine. It is being used to perform a range of analyses, including whole genome resequencing, gene-expression analysis, and small ribonucleic acid (sRNA) analysis.
In 2011 the Chinese National Development and Reform Commission (NDRC), Ministry of Finance, Ministry of Industry and Information Technology, and Ministry of Health and Family Planning approved the establishment of the Centre, entrusting BGI with its construction in a public-private partnership.
Synthetic genomics is unlike genetic modification in the sense that it does not use naturally occurring genes in its life forms. It may make use of custom designed base pair series, though in a more expanded and presently unrealized sense synthetic genomics could utilize genetic codes that are not composed of the two base pairs of DNA that are currently used by life.
The core technology is a silicon chip, contrasting with other ultrasound devices that use piezoelectric crystals. [17] The use of silicon makes the device far cheaper to manufacture. [17] The iQ received 13 different device clearances from the Food and Drug Administration. [17] The iQ sells for just over $2,000, and is now commercially ...